A newly released study has provided fresh insights into the impact of the pandemic on Canada, revealing significant levels of immunity within the population. However, amidst speculations surrounding a new COVID-19 variant arising from the Omicron lineage, concerns have arisen about a potential uptick in infections. The study’s findings indicate that even with substantial vaccine coverage and population immunity, the Omicron variants and subvariants managed to trigger an “unprecedented increase” in infections.
Dr. Christopher Labos, an epidemiologist and cardiologist, shed light on the study’s implications. He explained that during the Omicron wave, a notable 76 percent of the population experienced a COVID infection. This statistic challenges previous notions, as it suggests that approximately one in four Canadians have not been infected with the virus. Labos cautioned against complacency, emphasizing the importance of staying up to date with vaccinations.
Labos went on to raise concerns about the fall season, warning that Canada might once again witness the circulation of respiratory viruses like influenza and RSV. He noted that the vaccine rollout planned for the fall could include an Omicron subvariant-specific booster, potentially offering enhanced protection.
When questioned about the potential risk for individuals with underlying medical conditions or those who have not previously contracted COVID-19, Labos clarified that he wouldn’t use the term “concern.” Instead, he advocated for a “mindful” approach, stressing that COVID-19 remains in circulation. He underscored the necessity of taking preventative measures to safeguard against potential emergencies, highlighting that nobody would want to endure prolonged hours in an emergency room due to COVID-19 complications.